Fairvalue-Calculator Fairvalue-Calculator
EN DE

HansBiomed Corporation (042520) Fair Value & Analysis

Healthcare · KR · Market cap 363B KRW

Price25,050 KRW
Fair Value10,650 KRW
Upside-57.5%
Quality95/100
Evidence: Low Range 7,987 KRW – 13,312 KRW

Fair value as of: Jun 24, 2026

Analysis

HansBiomed Corporation (042520) currently trades at 25,050 KRW, while our model-based Fair Value estimate is 10,650 KRW — implying the stock looks roughly 57.5% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. The company provides ExFuse, a demineralized bone matrix with cancellous bone gel/putty; BellaFuse, a demineralized bone matrix; Genesis, a cancellous sponge block/filler; Pedi-Stick, a demineralized cortical bone stick; SureChip, a cancellous bone chip; OsteoGrow, a demineralized bone matrix inserter; BellaCell HD, an allograft dermal product that transplanted in a patient whose skin has been lost due to breast cancer; and SureDerm, an acellular dermal matrix. It also offers BELLAGEL, a breast prosthesis, internal, and gel-filled solution; MINT Lift, a PDO thread; EZ-Tcon solution; Lion HT/HN, a hair transplanter body/needle; and Scar Clinic, a scar management solution. The company was formerly known as Hans Medical Corp. and changed its name to HansBiomed Corporation in June 2000. Th…

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -9% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -5% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is HansBiomed Corporation (042520) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 10,650 KRW versus a price of 25,050 KRW — about −57% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 042520?
Our 21-model fair value for HansBiomed Corporation is 10,650 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 25,050 KRW.
What is the quality score of 042520?
HansBiomed Corporation has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.